Combining the strengths of MRVL®, our scientific team and partners continue to conduct groundbreaking studies. MRVL® has signed an agreement with the University of Northern Colorado to expand our research and development activities.
Research reports in the public domain suggest that scorpion venom may have a wide array of potential applications. Using nature as our guide, our team ultimately seeks to identify advanced therapeutics and conduct clinical trials so our scientists can verify the efficacy of Blue Scorpion Peptide CTX™.
We encourage you to do your research on the World Wide Web to explore additional information on scorpion venom.